2m 2m 2m 2m 2m 2m 2m
ROIVANT SCIENCES (ROIV)
NASDAQ
$35.43+$0.92 (+2.67%)
Price as of Jul 13, 2026 6:38 PM EDT- $25.7BMarket Cap
- 196.73%1-Year Change
- BiotechnologyIndustry
ROIVANT SCIENCES (ROIV)
$35.43+$0.92 (+2.67%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 10.84% | 78.0M | +12.2M (+15.65%) | Mar 31, 2026 |
MORGAN STANLEY | 7.21% | 51.8M | -6.5M (-12.60%) | Mar 31, 2026 |
BLACKROCK, INC. | 6.15% | 44.3M | +3.1M (+6.97%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 5.86% | 42.2M | +195,472 (+0.46%) | Dec 31, 2024 |
VANGUARD GROUP INC | 5.85% | 42.1M | +3.3M (+7.74%) | Dec 31, 2025 |
BLACKROCK INC. | 4.92% | 35.4M | -817,249 (-2.31%) | Jun 30, 2024 |
QVT FINANCIAL LP | 3.50% | 25.2M | -1.2M (-4.87%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 5.08% | 36.6M | +1.4M (+3.87%) | Mar 31, 2026 |
FIDELITY MT VERNON STREET TRUST | 2.41% | 17.4M | 0 (0.00%) | Feb 28, 2026 |
VANGUARD SPECIALIZED FUNDS | 1.33% | 9.6M | 0 (0.00%) | Apr 30, 2026 |
SPDR SERIES TRUST | 1.14% | 8.2M | 0 (0.00%) | Apr 30, 2026 |
INVESCO EXCHANGE-TRADED FUND TRUST | 0.82% | 5.9M | +4.4M (+73.89%) | Apr 30, 2026 |
T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.73% | 5.3M | 0 (0.00%) | Mar 31, 2026 |
MORGAN STANLEY INSTITUTIONAL FUND INC | 0.66% | 4.8M | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions8.7B (85.78%)
- Mutual Funds819.1M (8.10%)
- Insiders618.3M (6.12%)
- Other0 (0.00%)
Insider Transactions
- 6.12% (618.3M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 11Number of InsiderSelling (last 12 months)
- $20.8BAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
QVT Financial LP | Sell | Jun 30, 2026 | $436,766.40 | 12,380 | $35.28 | 13.7M |
MANCHESTER KEITH S | Sell | Jun 30, 2026 | $436,766.40 | 12,380 | $35.28 | 13.7M |
MANCHESTER KEITH S | Sell | Jun 30, 2026 | $7.1M | 200,000 | $35.45 | 1.7M |
Fitzgerald Meghan | Exempt | Jun 30, 2026 | $0.00 | 10,000 | $0.00 | 38,578 |
Fitzgerald Meghan | Exempt | Jun 30, 2026 | $88,000.00 | 10,000 | $8.80 | 52,963 |
Fitzgerald Meghan | Sell | Jun 30, 2026 | $349,000.00 | 10,000 | $34.90 | 42,963 |
QVT Financial LP | Sell | Jun 29, 2026 | $6.9M | 200,000 | $34.44 | 14.3M |
Epperly Melissa B, | Exempt | Jun 29, 2026 | $0.00 | 17,750 | $0.00 | 169,166 |
QVT Financial LP | Sell | Jun 29, 2026 | $20.8M | 600,000 | $34.59 | 13.7M |
MANCHESTER KEITH S | Sell | Jun 29, 2026 | $6.9M | 200,000 | $34.44 | 14.3M |
Epperly Melissa B, | Exempt | Jun 29, 2026 | $79,165.00 | 17,750 | $4.46 | 34,224 |
MANCHESTER KEITH S | Sell | Jun 29, 2026 | $20.8M | 600,000 | $34.59 | 13.7M |
Epperly Melissa B, | Sell | Jun 29, 2026 | $514,868.64 | 15,002 | $34.32 | 19,222 |
Epperly Melissa B, | Sell | Jun 29, 2026 | $95,383.08 | 2,748 | $34.71 | 16,474 |
QVT Financial LP | Sell | Jun 26, 2026 | $10.2M | 300,783 | $33.92 | 14.8M |
MANCHESTER KEITH S | Sell | Jun 26, 2026 | $10.2M | 300,783 | $33.92 | 14.8M |
QVT Financial LP | Sell | Jun 26, 2026 | $11.1M | 325,000 | $34.07 | 14.5M |
MANCHESTER KEITH S | Sell | Jun 26, 2026 | $11.1M | 325,000 | $34.07 | 14.5M |
Venker Eric President & Immunovant CEO | Exempt | Jun 24, 2026 | $0.00 | 200,000 | $0.00 | 4.2M |
Venker Eric President & Immunovant CEO | Exempt | Jun 24, 2026 | $770,000.00 | 200,000 | $3.85 | 1.8M |
Venker Eric President & Immunovant CEO | Sell | Jun 24, 2026 | $5.1M | 153,766 | $33.05 | 1.7M |
Venker Eric President & Immunovant CEO | Sell | Jun 24, 2026 | $1.5M | 46,234 | $33.51 | 1.6M |
Pulik Richard CFO | In Kind | Jun 20, 2026 | $66,914.47 | 2,129 | $31.43 | 276,420 |
Humes Jennifer Chief Accounting Officer | In Kind | Jun 20, 2026 | $112,582.26 | 3,582 | $31.43 | 109,782 |
Humes Jennifer Chief Accounting Officer | Sell | Apr 08, 2026 | $384,073.06 | 13,538 | $28.37 | 84,191 |
Sukhatme Mayukh President & CIO | In Kind | Mar 31, 2026 | $5.2M | 187,512 | $27.70 | 18.7M |
Torti Frank President and Vant Chair | In Kind | Mar 31, 2026 | $4.4M | 160,035 | $27.70 | 13.6M |
Gline Matthew CEO | In Kind | Mar 31, 2026 | $8.4M | 304,684 | $27.70 | 17.0M |
Sukhatme Mayukh President & CIO | Exempt | Mar 30, 2026 | $15.0M | 1.3M | $11.50 | 0 |
Gline Matthew CEO | Exempt | Mar 30, 2026 | $25.0M | 2.2M | $11.50 | 0 |